Menu Search
Equities

Micropos Medical AB (publ)

MPOS:AKT

Micropos Medical AB (publ)

Actions
  • Price (SEK)1.99
  • Today's Change-0.06 / -2.93%
  • Shares traded21.70k
  • 1 Year change-9.40%
  • Beta0.4683
Data delayed at least 15 minutes, as of Sep 13 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Micropos Medical AB (publ) had net income fall 26.57% from a loss of 18.60m to a larger loss of 23.54m despite revenues that grew 50.23% from 1.09m to 1.64m over the same period.
Gross margin79.96%
Net profit margin-845.91%
Operating margin-857.54%
Return on assets-84.10%
Return on equity-113.54%
Return on investment-111.33%
More ▼

Cash flow in SEKView more

In 2023, Micropos Medical AB (publ) increased its cash reserves by 75.61%, or 2.59m. Cash Flow from Financing totalled 25.51m or 1,557.41% of revenues. In addition the company used 22.92m for operations while cash from investing was breakeven.
Cash flow per share-0.1692
Price/Cash flow per share--
Book value per share0.1341
Tangible book value per share0.1238
More ▼

Balance sheet in SEKView more

Micropos Medical AB (publ) uses little debt in its capital structure as supported by a debt to capital ratio of 1.84%.
Current ratio3.77
Quick ratio3.18
Total debt/total equity0.0188
Total debt/total capital0.0184
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.